Announcement on Voluntary Disclosure of Obtaining Clinical Trial Approval from the National Medical Products Administration for the Indications for the Treatment and Prevention of Human Bronchovirus Infection by the YKYY018 Inhalation Aerosol of Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment